Decipher Labs Ltd (DECIPHER) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Decipher Labs Ltd on NSE and BSE, with an AI summary of each filing.
Voting Results and Scrutinizer''s Report for 40th Annual General Meeting held on 30th September, 2026 at 11:00 AM.
Annual General Meeting · 30 Sept 2026, 8:09 pm
Outcome and Proceedings of 40th Annual General Meeting held on 30th September, 2026 at 11:00 AM.
Annual General Meeting · 30 Sept 2026, 8:06 pm
Newspaper Advertisement for the Annual General Meeting to be held for the FY_2025-26.
Annual General Meeting · 09 Sept 2026, 7:59 pm
Intimation of Book Closure date and Cut Off Date for Annual General Meeting scheduled to be held on 30th September, 2026.
Annual General Meeting · 08 Sept 2026, 11:06 pm
40th Annual Report for the Financial Year 2025-26
Others (Uncategorized) · 08 Sept 2026, 11:04 pm
Notice of the 40th Annual General Meting for the Financial Year 2025-26 under regulation 34 of SEBI (LODR), Regulations 2015.
Annual General Meeting · 08 Sept 2026, 11:00 pm
Appointment of Auditors and resignation of Independent Director of the Company.
Change in Management · 06 Sept 2026, 12:29 am
Decipher Labs Approves Auditor Appointments and Reconstitutes Board Committees Decipher Labs announced key board approvals from its meeting on 5th Sep'26. The company proposed appointing M/s. Ramanatham & Rao as Statutory Auditors for five years, covering FY27 to FY31, subject to shareholder approval, and appointed Sushant Mohan Lal as Internal Auditor for FY27. Additionally, Independent Director Lakshmi Vijaya Nimmala resigned effective 5th Sep'26 citing pre-occupation, prompting a reconstitution of the Audit, Nomination & Remuneration, and Stakeholder Relationship committees. The AGM for FY26 is scheduled for 30th Sep'26 via video conference.
Outcome of Board Meeting held on 05.09.2026.
Others (Uncategorized) · 06 Sept 2026, 12:26 am
Decipher Labs Announces Auditor Appointments, Board Resignation, and Reconstitutes Committees Decipher Labs Limited approved the appointment of M/s. Ramanatham & Rao., Chartered Accountants, as Statutory Auditors for a five-year term from FY'26-27 to FY'30-31, subject to shareholder approval. The board appointed Sushant Mohan Lal as Internal Auditor for FY'26-27 and accepted the resignation of Independent Director Lakshmi Vijaya Nimmala effective 5th Sep'26 due to preoccupation. Consequently, the company reconstituted its Audit, Nomination and Remuneration, and Stakeholder Relationship committees. The Annual General Meeting for FY'25-26 is scheduled for 30th Sep'26 via video conference.
Announcement under Regulation 30 of SEBI (Listng Obligations and Disclosure Requirement), Regulations, 2015.
Others (Uncategorized) · 14 Aug 2026, 11:51 pm
Decipher Labs Announces Routine Statutory Auditor Rotation Decipher Labs (BSE: 524752) announced its statutory auditor, M/s. Ramanatham & Rao, will retire upon concluding the 40th AGM for FY26, to be held by 30th Sep'26. The change is a mandatory, procedural rotation due to the expiry of the maximum permissible tenure under the Companies Act, 2013. The company confirmed the outgoing auditor has not raised any concerns or issues, and the cessation is not due to resignation or disagreement. This is a standard governance-related event with no adverse implications noted.
Revised Un-audited Financial Results for the quarter ended 30.06.2026.
Financial Result · 14 Aug 2026, 12:20 am
Decipher Labs Submits Revised Q1FY27 Results, Correcting Segment Information Decipher Labs has submitted revised unaudited financial results for the quarter ended 30 Jun'26, citing a typographical error in the previously filed Segment Information. All other financial figures remain unchanged. For Q1FY27, the company reported a standalone net loss of ₹7.93 lakh, a significant decline from a profit of ₹5.59 lakh YoY. Standalone revenue from operations dropped sharply by 88% YoY to ₹9.81 lakh. On a consolidated basis, the net loss for Q1FY27 was ₹218.57 lakh, compared to a loss of ₹342.67 lakh YoY.
Appointment of Mr. Bhupendralal Waghray as an Additional Director (Independent Category) of the company for a period of Five (5) years w.e.f. 13.08.2026 subject to approval of shareholders.
Change in Management · 13 Aug 2026, 10:54 pm
Decipher Labs Q1FY27 Results and Board Updates Decipher Labs reported a Q1FY27 consolidated net loss of ₹218.57 Lakhs, a significant decline from a ₹35.79 Lakh profit QoQ and a deeper loss than ₹342.67 Lakhs YoY. Revenue from operations fell to ₹241.39 Lakhs, down 33% QoQ and 17.4% YoY. The Board approved the unaudited results for the quarter ended 30th Jun’26 and appointed Mr. Bhupendralal Waghray as an Additional Independent Director for five years, effective 13th Aug’26, subject to shareholder approval.
Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30.06.2026.
Financial Result · 13 Aug 2026, 10:51 pm
Decipher Labs Q1FY27 Results and Board Appointment Decipher Labs reported Q1FY27 consolidated net loss of ₹218.57 Lakhs on revenue of ₹241.39 Lakhs. This compares to a YoY net loss of ₹342.67 Lakhs on revenue of ₹292.37 Lakhs. Standalone results showed a net loss of ₹7.93 Lakhs against a YoY profit of ₹5.59 Lakhs. The Board approved the appointment of Mr. Bhupendralal Waghray as an Additional Independent Director for a five-year term, effective 13 Aug'26, subject to shareholder approval. Mr. Waghray has 38 years of experience in government tax administration.
Outcome of Board Meeting held on 13th August, 2026.
Outcome · 13 Aug 2026, 10:44 pm
Decipher Labs Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakhs) ■ Revenue: 241 (-17.4% YoY | -33.0% QoQ) ■ EBITDA: -215 (+35.1% YoY | Profit to Loss QoQ) ■ EBITDA Margin (%): -89.2 (+2421 bps YoY | Profit to Loss QoQ) ■ PAT: -219 (+36.2% YoY | Profit to Loss QoQ) ■ EPS (INR): -2.16 (+36.3% YoY | -517.1% QoQ) Decipher Labs Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakhs) Segmental Performance Manufacturing and Trading of Pharmaceutical drugs ■ Revenue: -67.1 (Positive to Negative YoY) ■ EBIT: 25.1 (+422.3% YoY | +224.3% QoQ) ■ EBIT Margin (%): -37.4 (Profit to Loss YoY) Consultancy Services ■ Revenue: -737 (Positive to Negative YoY | Positive to Negative QoQ) ■ EBIT: 150 (Loss to Profit YoY | +760.5% QoQ) ■ EBIT Margin (%): -20.4 (+13395 bps YoY | Profit to Loss QoQ)
Decipher Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve 1. Un-audited financial results ....
Intimation · 13 Aug 2026, 5:30 am
Decipher Labs Board Meeting Set for Aug 13th to Approve Q1FY27 Results Decipher Labs Limited has scheduled a Board Meeting on 13th Aug'26 to consider and approve its un-audited standalone and consolidated financial results for the quarter ended 30th Jun'26. The agenda also includes the approval of the Limited Review Report for the same period. This meeting will be crucial for evaluating the company's Q1FY27 performance.
Audited standalone and consolidated financial results & statements for the quarter and year ended 31.03.2026
Financial Result · 30 May 2026, 10:28 pm
Decipher Labs Reports FY26 Results with Widened Consolidated Net Loss Decipher Labs reported consolidated results for the quarter ended 31st Mar'26, posting a net loss of ₹35.79 lakhs against a loss of ₹410.61 lakhs YoY. Revenue from operations was ₹360.40 lakhs, up from ₹350.01 lakhs YoY. For the full year FY26, the consolidated net loss widened to ₹308.43 lakhs from ₹508.02 lakhs in FY25, while revenue decreased to ₹1,405.40 lakhs from ₹2,261.25 lakhs YoY. Standalone FY26 net loss was ₹24.68 lakhs versus a loss of ₹44.02 lakhs in FY25.
Outcome of the Board Meeting held on 30.05.2026
Outcome · 30 May 2026, 10:22 pm
Decipher Labs Ltd - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Lakh) ■ Revenue: 360 (+3.0% YoY | +12.2% QoQ) ■ EBITDA: 22.7 (Loss to Profit YoY | Loss to Profit QoQ) ■ EBITDA Margin (%): 6.3 (Loss to Profit YoY | Loss to Profit QoQ) ■ PAT: 86.1 (Loss to Profit YoY | Loss to Profit QoQ) ■ EPS (INR): -0.35 (+91.4% YoY | +34.0% QoQ) Decipher Labs Ltd - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Lakh) Segmental Performance Manufacturing and Trading of Pharmaceutical drugs ■ Revenue: 0.0 (-100.0% YoY) ■ EBIT: 7.7 (+930.7% YoY | Loss to Profit QoQ) ■ EBIT Margin (%): 0.0 (-332 bps YoY) Consultancy Services ■ Revenue: 360 (+10.1% YoY | +12.2% QoQ) ■ EBIT: 17.4 (Loss to Profit YoY | Loss to Profit QoQ) ■ EBIT Margin (%): 4.8 (Loss to Profit YoY | Loss to Profit QoQ)
Decipher Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve 1. Audited Financial results ....
Intimation · 30 May 2026, 5:30 am
Decipher Labs Board Meeting Set to Approve Q4 FY26 Financial Results Decipher Labs has scheduled a Board Meeting on 30 May'26 to consider and approve its audited standalone and consolidated financial results for the quarter and year ended 31 Mar'26. The board will also review the corresponding audit report for the financial year. This meeting is critical for the announcement of the company's Q4 and full-year FY26 earnings performance.
<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> ....
Others (Uncategorized) · 22 Apr 2026, 8:28 pm
Decipher Labs Confirms It Is Not Classified as a Large Corporate Decipher Labs Limited has formally notified the BSE that it does not fall under the "Large Corporate" (LC) category as defined by the SEBI circular dated 19 Oct'23. This declaration, filed on 22 Apr'26 for FY26, confirms the company is not subject to the mandatory requirement of raising a portion of its incremental borrowings through debt securities. Consequently, all related fields for mandatory borrowing and potential shortfalls were reported as "Not Applicable" or "Nil" for the reporting period.
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Others (Uncategorized) · 21 Apr 2026, 10:08 pm
Decipher Labs Confirms It Does Not Qualify as a Large Corporate Decipher Labs Limited announced on 21-Apr'26 that it does not qualify as a "Large Corporate" for FY27 under SEBI's framework. The company meets only the first of three required criteria (being listed), but fails to meet the other two: outstanding long-term borrowings of ₹1,000 crore or more and a credit rating of "AA" or higher. Its outstanding borrowing was just ₹0.50 crore as of 31-Mar'26. Consequently, the mandatory disclosure and borrowing requirements for Large Corporates are not applicable.
Unaudited Financial Results for the quarter and nine months ended 31.12.2025.
Financial Result · 12 Feb 2026, 10:21 pm
Decipher Labs Reports Widened Consolidated Loss for Q3 FY26 Decipher Labs reported a widened consolidated net loss of ₹53.88 lakh for Q3 FY26, ending 31st Dec'25, compared to a profit of ₹2.01 lakh QoQ and a loss of ₹59.27 lakh YoY. Revenue from operations declined 25.5% QoQ to ₹321.26 lakh. For the nine months, consolidated net loss expanded to ₹394.54 lakh from ₹97.41 lakh YoY, while revenue fell 45.3% to ₹1,045.00 lakh. Standalone net loss for the quarter narrowed to ₹1.41 lakh from ₹11.55 lakh QoQ and ₹8.97 lakh YoY.
Outcome of Board Meeting held on Thursday, 12th February, 2026.
Outcome · 12 Feb 2026, 10:16 pm
Decipher Labs Limited - Financial Result for the Quarter ended 31st Dec'25 (Consolidated, INR Lakhs) ■ Revenue: 321 (-44.7% YoY | -25.5% QoQ) ■ EBITDA: -42.9 (+31.2% YoY | Profit to Loss QoQ) ■ EBITDA Margin (%): -13.4 (-262 bps YoY | Profit to Loss QoQ) ■ PAT: -53.9 (+9.1% YoY | Profit to Loss QoQ) ■ EPS (INR): -0.53 (+10.2% YoY | Profit to Loss QoQ) Decipher Labs Limited - Financial Result for the Quarter ended 31st Dec'25 (Consolidated, INR Lakhs) Segmental Performance Manufacturing and Trading of Pharmaceutical drugs ■ Revenue: -5.3 (+36.5% YoY | +78.7% QoQ) ■ EBIT: -5.3 (+36.5% YoY | +78.7% QoQ) ■ EBIT Margin (%): 100 (+0 bps YoY | +0 bps QoQ) Consultancy Services ■ Revenue: -48.0 (+4.4% YoY | Positive to Negative QoQ) ■ EBIT: -48.0 (+4.4% YoY | Profit to Loss QoQ) ■ EBIT Margin (%): 100 (+0 bps YoY | +0 bps QoQ)
Scrutinizer''s Report for the Extra-ordinary General meeting held on 12.02.2026.
Extra Ordinary General Meeting · 12 Feb 2026, 9:15 pm
Shareholders Approve Appointment of Dalavath Amar Singh as Whole-Time Director At its EGM on 12 Feb'26, Decipher Labs Limited shareholders approved the appointment of Mr. Dalavath Amar Singh as Director and Whole-Time Director via a special resolution. The resolution passed with 100% of the 237,806 valid votes cast in favour. Voting was conducted through remote e-voting and e-voting during the meeting. Public non-institutional shareholders accounted for all votes cast, representing 2.8174% of their total shareholding. No votes were cast against the resolution, and no votes were declared invalid.
Outcome of the Extra-ordinary General Meeting held on 12.02.2026.
Extra Ordinary General Meeting · 12 Feb 2026, 9:10 pm
Decipher Labs Shareholders Approve Appointment of Whole-Time Director Decipher Labs Limited announced that shareholders approved the appointment of Mr. Dalavath Amarsingh as Director and Whole-Time Director at its EGM on 12 Feb'26. The special resolution passed with 100% of votes in favour from both institutional and non-institutional public shareholders who participated in the e-voting. A total of 237,806 votes, representing 2.35% of total shares, were polled. The promoter and promoter group, holding 1,659,075 shares, did not cast any votes. The meeting was attended by 41 members via video conference.
Decipher Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve 1. Un-audited financial results ....
Intimation · 12 Feb 2026, 5:30 am
Decipher Labs Board Meeting Set for Q3 FY26 Results Decipher Labs (Scrip: 524752) has scheduled a Board Meeting for 12th Feb'26 to consider and approve its unaudited standalone and consolidated financial results for the quarter and nine months ended 31st Dec'25. The agenda also includes the limited review report for the same period. This meeting will be crucial for assessing the company's financial performance in the third quarter of fiscal year 2026.
EGM will be held on 12.02.2026
Extra Ordinary General Meeting · 21 Jan 2026, 8:36 pm
Decipher Labs to Appoint Whole-Time Director at Feb '26 EGM Decipher Labs Limited has scheduled an Extra-Ordinary General Meeting for 12th Feb'26 to approve the appointment of Mr. Dalavath Amar Singh as Director and Whole-Time Director. The appointment is proposed for a two-year term, effective from 13th Nov'25, with an annual remuneration of Rs. 6 lakhs. This move follows a period of business expansion which has impacted recent profitability. The cut-off date for e-voting eligibility is 05th Feb'26, with the remote e-voting window open from 09th Feb'26 to 11th Feb'26.